Serum-Dependence of Affinity-Mediated VEGF Release from Biomimetic Microspheres

被引:22
作者
Belair, David G. [1 ]
Khalil, Andrew S. [1 ]
Miller, Michael J. [2 ]
Murphy, William L. [1 ,3 ]
机构
[1] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA
基金
美国国家卫生研究院;
关键词
ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR-MATRIX; SUSTAINED-RELEASE; COMPARTMENT MODEL; HEPARAN-SULFATE; FACTOR-RECEPTOR; G1; PHASE; IN-VITRO; HYDROGELS; BINDING;
D O I
10.1021/bm500177c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) activity is demanded proteolysis to release the sequestered VEGF. Numerous 7 studies have demonstrated that VEGF activity mediates cellular events leading to angiogenesis and capillary formation in vivo. This has motivated the study of biomaterials to sustain VEGF release, and in many cases, the materials are inspired by the structure and function of the native ECM. However, there remains a need for materials that can bind to VEGF with high specificity, as the in vivo environment is rich in a variety of growth factors (GFs) and GF-binding moieties. Here we describe a strategy to control VEGF release using hydrogel microspheres with tethered peptides derived from VEGF receptor 2 (VEGFR2). Using biomaterials covalently modified with varying concentrations of two distinct VEGFR2-derived peptides with varying serum stability, we analyzed both biomaterial and environmental variables that influence VEGF release and activity. The presence of tethered VEGF-binding peptides (VBPs) resulted in significantly extended VEGF release relative to control conditions, and the resulting released VEGF significantly increased the expansion of human umbilical vein endothelial cells in culture. VEGF release rates were also strongly influenced by the concentration of serum. The presence of Feline McDonough Sarcoma-like tyrosine kinase 1 (sFlt-1), a serumborne receptor fragment derived from VEGF receptor 1, increased VEGF release rates, although sFlt-1 was not sufficient to recapitulate the release profile of VEGF in serum. Further, the influence of serum on VEGF release was not due to protease activity or nonspecific VEGF interactions in the presence of serum-borne heparin. VEGF release kinetics correlated well with a generalizable mathematical model describing affinity-mediated release of VEGF from hydrogel microspheres in defined conditions. Modeling results suggest a potential mechanism whereby competition between VEGF and multiple VEGF-binding serum proteins including sFlt-1, soluble kinase insert domain receptor (sKDR), and alpha 2-macroglobulin (alpha 2-M) likely influenced VEGF release from microspheres. The materials and mathematical model described in this approach may be useful in a range of applications in which sustained, biologically active GF release of a specific GF is desirable.
引用
收藏
页码:2038 / 2048
页数:11
相关论文
共 80 条
  • [1] Extracellular matrix, inflammation, and the angiogenic response
    Arroyo, Alicia G.
    Iruela-Arispe, M. Luisa
    [J]. CARDIOVASCULAR RESEARCH, 2010, 86 (02) : 226 - 235
  • [2] Effect of different mitogens and serum concentration on HUVEC morphology and characteristics: Implication on use of higher passage cells
    Bala, Kanchan
    Ambwani, Kiran
    Gohil, Nivedita Karmakar
    [J]. TISSUE & CELL, 2011, 43 (04) : 216 - 222
  • [3] Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
    Banks, RE
    Forbes, MA
    Kinsey, SE
    Stanley, A
    Ingham, E
    Walters, C
    Selby, PJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 956 - 964
  • [4] Barleon B, 1997, J BIOL CHEM, V272, P10382
  • [5] Specific VEGF sequestering to biomaterials: Influence of serum stability
    Belair, David G.
    Murphy, William L.
    [J]. ACTA BIOMATERIALIA, 2013, 9 (11) : 8823 - 8831
  • [6] Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-I, in fluid samples: development and application of two new immunoassays
    Belgore, FM
    Blann, AD
    Lip, GY
    [J]. CLINICAL SCIENCE, 2001, 100 (05) : 567 - 575
  • [7] Belotti D., 2003, CANCER RES, P5224
  • [8] Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806
  • [9] Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres
    Borselli, Cristina
    Ungaro, Francesca
    Oliviero, Olimpia
    d'Angelo, Ivana
    Quaglia, Fabiana
    La Rotonda, Maria I.
    Netti, Paolo A.
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 92A (01) : 94 - 102
  • [10] Cellular and molecular basis of wound healing in diabetes
    Brem, Harold
    Tomic-Canic, Marjana
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) : 1219 - 1222